Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism

被引:2
|
作者
Ozdemir, Suna [1 ]
Ozdemir, Mustafa
Gorkemli, Huseyin [1 ]
Kiyici, Aysel
Bodur, Sait
机构
[1] Selcuk Univ, Meram Med Fac, Dept Gynecol & Obstet, Konya, Turkey
关键词
Polycystic ovary syndrome; cutaneous features; hyperandrogenism; metabolic abnormality; ACNE SEVERITY; THECA CELLS; ADULT WOMEN; MANIFESTATIONS; HEALTH; PREVALENCE; MANAGEMENT; HIRSUTISM; DISEASE;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective. To investigate biochemical and metabolic abnormalities in relation with cutaneous features of polycystic ovary syndrome (PCOS). Design. Prospective descriptive analysis. Setting. University-based tertiary care. Sample. One-hundred and fifteen untreated consecutive women diagnosed as having PCOS. Methods. Each woman underwent an evaluation of body habitus, acne, hirsutism, seborrhea, androgenic alopecia and acanthosis nigricans. Associations between cutaneous features and hormonal and metabolic parameters were analyzed by means of multivariate logistic regression models. Main outcome measures. Prevalence of cutaneous features in PCOS and associations among the features and biochemical and metabolic parameters. Results. The prevalence of acne, hirsutism, seborrhea, androgenetic alopecia and acanthosis nigricans was 53%, 73.9%, 34.8%, 34.8% and 5.2%, respectively. Acne was not associated with the hormonal, metabolic and anthropometric variables. Hirsutism had positive associations with total testosterone, fasting glucose and total cholesterol, and a negative association with age. Seborrhea was found to be related with free testosterone, fasting glucose and insulin. A negative association was determined among androgenic alopecia and free testosterone, low-density lipoprotein and insulin. Conclusions. Acne and androgenic alopecia are not good markers for the hyperandrogenism in PCOS. Hirsutism appears to be strongly related with hyperandrogenism and metabolic abnormalities in PCOS women.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 50 条
  • [31] The Gut Microbiome in Polycystic Ovary Syndrome and Its Association with Metabolic Traits
    Lull, Kreete
    Arffman, Riikka K.
    Sola-Leyva, Alberto
    Molina, Nerea M.
    Aasmets, Oliver
    Herzig, Karl-Heinz
    Plaza-Diaz, Julio
    Franks, Stephen
    Morin-Papunen, Laure
    Tapanainen, Juha S.
    Salumets, Andres
    Altmae, Signe
    Piltonen, Terhi T.
    Org, Elin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (03): : 858 - 871
  • [32] Markers of insulin resistance and metabolic syndrome in polycystic ovary
    Trimeche, S.
    Safer, M. Abid
    Chaieb, M. Chadli
    Ajina, M. Zaouali
    Elghezal, R. Braham
    Beizig, A. Maaroufi
    Ach, K.
    Njah, M. Kacem
    Chaieb, L.
    DIABETES & METABOLISM, 2011, 37 : A70 - A70
  • [33] Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome
    De Leo, Vincenzo
    Di Sabatino, Alessandra
    Musacchio, Maria C.
    Morgante, Giuseppe
    Scolaro, Valeria
    Cianci, Antonio
    Petraglia, Felice
    CONTRACEPTION, 2010, 82 (03) : 276 - 280
  • [34] NAFLD in Polycystic Ovary Syndrome: Association with PNPLA3 and Metabolic Features
    Recuero, Amanda Medeiros
    Gomes, Larissa Garcia
    Rosa Maciel, Gustavo Arantes
    Malta, Fernanda de Mello
    Salles, Ana Paula Moreira
    Paranagua Vezozzo, Denise Cerqueira
    Baracat, Edmund Chada
    Rebello Pinho, Joao Renato
    Carrilho, Flair Jose
    Stefano, Jose Tadeu
    Oliveira, Claudia P.
    BIOMEDICINES, 2022, 10 (11)
  • [35] Association of IL-29 with the lipid metabolic features of polycystic ovary syndrome
    Liu, Mulin
    Dong, Sicong
    Li, Shijun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (09): : 9552 - 9558
  • [36] Polycystic ovary syndrome and metabolic syndrome
    Auernhammer, CJ
    Engelhardt, D
    Parhofer, KG
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (18) : 971 - 977
  • [37] Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome
    Alpanes, Macarena
    Luque-Ramirez, Manuel
    Angeles Martinez-Garcia, M.
    Fernandez-Duran, Elena
    Alvarez-Blasco, Francisco
    Francisco Escobar-Morreale, Hector
    FERTILITY AND STERILITY, 2015, 103 (03) : 795 - U519
  • [38] Can the source of hyperandrogenism in adolescents with polycystic ovary syndrome predict metabolic phenotype?
    Al Nofal, Alaa
    Viers, Lyndsay D.
    Javed, Asma
    GYNECOLOGICAL ENDOCRINOLOGY, 2017, 33 (11) : 882 - 887
  • [39] Metabolic syndrome and polycystic ovary syndrome
    Sobstyl, Malgorzata
    Tkaczuk-Wlach, Joanna
    Sobstyl, Jacek
    Jakiel, Grzegorz
    PRZEGLAD MENOPAUZALNY, 2011, 10 (01): : 74 - 78
  • [40] The metabolic syndrome in polycystic ovary syndrome
    P. A. Essah
    J. E. Nestler
    Journal of Endocrinological Investigation, 2006, 29 : 270 - 280